Literature DB >> 25789404

Impact of recommendations on crushing medications in geriatrics: from prescription to administration.

Gwladys Bourdenet1, Sophie Giraud2, Marion Artur1, Sophie Dutertre1, Marie Dufour1, Marie Lefèbvre-Caussin3, Alice Proux1, Sandrine Philippe4, Corinne Capet1, Magali Fontaine-Adam4, Karine Kadri5, Isabelle Landrin1, Emmanuelle Gréboval6, Myriam Touflet2, Jules Nanfack2, Christine Tharasse4, Rémi Varin4, Elise Rémy3, Mikaël Daouphars4, Jean Doucet1,3.   

Abstract

The practice of crushing drugs is very common in geriatric units. In 2009 a first study, performed in all geriatric units of a university hospital, showed that numerous errors were made during prescription, preparation and administration. The aim of this second prospective study was to assess the impact of regional and national recommendations in the same geriatric units. A survey of 719 patients (85.3 ± 6.7 years) was performed in 2013. For each patient who received crushed drugs, we recorded the reason the drugs were crushed, pharmacological classes, galenic presentations and the technique used for preparation and administration. Results were compared to the previous study. The number of patients receiving drugs after crushing was significantly lower than in the previous study (22.9% vs. 32.3%, P < 0.001). The number of crushed drugs was lower too (594 per 165 patients vs. 966 per 224 patients (P < 0.01). The main indication for crushing drugs remained swallowing disorders. The dosage form prevented crushing in 24.9% of drugs (vs. 42.0% in 2009, P < 0.001), but the drugs generally remained crushed all together. A mortar was used less often (38.6% vs. 92.6%, P < 0.001), with preference for individual-specific cups (56.1%). Mortars were more often cleaned between each patient (56.0% vs. 11.6%). The vehicle was more often neutral (water 88.5% vs. 5.7%, P < 0.001). This second study shows that regional and national recommendations have led to an overall improvement of practices for crushing drugs. Technical improvements are still possible, in association with appropriate pharmacological studies.
© 2015 Société Française de Pharmacologie et de Thérapeutique.

Entities:  

Keywords:  crushed drugs; elderly; swallowing disorders

Mesh:

Substances:

Year:  2015        PMID: 25789404     DOI: 10.1111/fcp.12116

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  6 in total

1.  Swallowing Tablets and Capsules Increases the Risk of Penetration and Aspiration in Patients with Stroke-Induced Dysphagia.

Authors:  Julia T Schiele; Heike Penner; Hendrik Schneider; Renate Quinzler; Gabriele Reich; Nikolai Wezler; William Micol; Peter Oster; Walter E Haefeli
Journal:  Dysphagia       Date:  2015-07-24       Impact factor: 3.438

Review 2.  Solid Oral Dosage Forms Use in Adults with Neurological Disorders and Swallowing Difficulties: A Scoping Review.

Authors:  Carolina Justus Buhrer Ferreira-Neto; Rayza Assis de Andrade; Fernanda Stumpf Tonin; Astrid Wiens
Journal:  Dysphagia       Date:  2021-10-15       Impact factor: 2.733

3.  Assessment of Clinical Practices for Crushing Medication in Geriatric Units.

Authors:  M Fodil; D Nghiem; M Colas; S Bourry; A-S Poisson-Salomon; H Rezigue; C Trivalle
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

4.  Oral medicine modification for older adults: a qualitative study of nurses.

Authors:  Aoife Mc Gillicuddy; Abina M Crean; Maria Kelly; Laura Sahm
Journal:  BMJ Open       Date:  2017-12-14       Impact factor: 2.692

5.  Drug loss while crushing tablets: Comparison of 24 tablet crushing devices.

Authors:  Min Yew Thong; Yady J Manrique; Kathryn J Steadman
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

6.  Preparation and physicochemical stability of 50 mg/mL hydroxychloroquine oral suspension in SyrSpend SF PH4 (dry).

Authors:  Guillaume Binson; Nicolas Venisse; Alexis Sauvaget; Astrid Bacle; Pauline Lazaro; Antoine Dupuis
Journal:  Int J Antimicrob Agents       Date:  2020-10-16       Impact factor: 15.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.